{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:52:56Z","timestamp":1788537176851,"version":"build-2803163510"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571397"],"award-info":[{"award-number":["81571397"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771533"],"award-info":[{"award-number":["81771533"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00325","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:33:11Z","timestamp":1559046791000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Anti-m\u00fcllerian Hormone for the Prediction of Ovarian Response in Progestin-Primed Ovarian Stimulation Protocol for IVF"],"prefix":"10.3389","volume":"10","author":[{"given":"Jialyu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renfei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice","volume":"20","author":"La Marca","year":"2014","journal-title":"Hum Reprod Update."},{"key":"B2","doi-asserted-by":"publisher","first-page":"398","DOI":"10.2174\/138920112799361972","article-title":"Possibilities and limits of ovarian reserve testing in ART","volume":"13","author":"La Marca","year":"2012","journal-title":"Curr Pharm Biotechnol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.fertnstert.2014.12.093","article-title":"Testing and interpreting measures of ovarian reserve: a committee opinion","volume":"103","year":"2015","journal-title":"Fertil Steril."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1093\/humrep\/dem101","article-title":"Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women","volume":"22","author":"Tsepelidis","year":"2007","journal-title":"Hum Reprod."},{"key":"B5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-Mullerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update."},{"key":"B6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.rbmo.2015.06.015","article-title":"Assessing ovarian response: antral follicle count versus anti-Mullerian hormone","volume":"31","author":"Fleming","year":"2015","journal-title":"Reprod Biomed Online."},{"key":"B7","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/humupd\/dmu020","article-title":"Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications","volume":"20","author":"Broer","year":"2014","journal-title":"Hum Reprod Update."},{"key":"B8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","article-title":"Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis","volume":"100","author":"Broer","year":"2013","journal-title":"Fertil Steril."},{"key":"B9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/humupd\/dms041","article-title":"Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach","volume":"19","author":"Broer","year":"2013","journal-title":"Hum Reprod Update."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1093\/humrep\/des101","article-title":"The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments","volume":"27","author":"Anckaert","year":"2012","journal-title":"Hum Reprod."},{"key":"B11","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.rbmo.2016.07.003","article-title":"Anti-Mullerian hormone for prediction of ovarian response in Chinese infertile women undergoing IVF\/ICSI cycles: a prospective, multi-centre, observational study","volume":"33","author":"Li","year":"2016","journal-title":"Reprod Biomed Online."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e6495","DOI":"10.1097\/md.0000000000006495","article-title":"Ovarian response prediction in controlled ovarian stimulation for IVF using anti-Mullerian hormone in Chinese women: a retrospective cohort study","volume":"96","author":"Zheng","year":"2017","journal-title":"Medicine (Baltimore)."},{"key":"B13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/humrep\/deu266","article-title":"Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Mullerian hormone","volume":"30","author":"Hamdine","year":"2015","journal-title":"Hum Reprod."},{"key":"B14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00404-016-4274-8","article-title":"Retrospective cohort study: AMH is the best ovarian reserve markers in predicting ovarian response but has unfavorable value in predicting clinical pregnancy in GnRH antagonist protocol","volume":"295","author":"Xu","year":"2017","journal-title":"Arch Gynecol Obstet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","article-title":"Antimullerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients","volume":"99","author":"Arce","year":"2013","journal-title":"Fertil Steril."},{"key":"B16","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/humrep\/den480","article-title":"Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception","volume":"24","author":"Nelson","year":"2009","journal-title":"Hum Reprod."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1093\/humrep\/der182","article-title":"Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF","volume":"26","author":"Yates","year":"2011","journal-title":"Hum Reprod."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1093\/humrep\/dem270","article-title":"Are GnRH antagonists comparable to agonists for use in IVF?","volume":"22","author":"Huirne","year":"2007","journal-title":"Hum Reprod."},{"key":"B19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.rbmo.2011.06.011","article-title":"The journey from the old to the new AMH assay: how to avoid getting lost in the values","volume":"23","author":"Nelson","year":"2011","journal-title":"Reprod Biomed Online."},{"key":"B20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.fertnstert.2013.09.015","article-title":"Race\/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race\/ethnic groups of healthy, regularly cycling women","volume":"101","author":"Bleil","year":"2014","journal-title":"Fertil Steril."},{"key":"B21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil Steril."},{"key":"B22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/humupd\/dmw047","article-title":"New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF","volume":"23","author":"Massin","year":"2017","journal-title":"Hum Reprod Update."},{"key":"B23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12958-017-0291-0","article-title":"Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders","volume":"15","author":"Chen","year":"2017","journal-title":"Reprod Biol Endocrinol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e2939","DOI":"10.1097\/md.0000000000002939","article-title":"Controlled ovarian stimulation using medroxyprogesterone acetate and hMG in patients with polycystic ovary syndrome treated for IVF: a double-blind randomized crossover clinical trial","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltimore)."},{"key":"B25","doi-asserted-by":"publisher","first-page":"11927","DOI":"10.1038\/s41598-017-12151-7","article-title":"Use of medroxyprogesterone acetate in women with ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"7","author":"Guo","year":"2017","journal-title":"Sci Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s00404-017-4537-z","article-title":"Neonatal outcomes and congenital malformations in children born after human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles","volume":"296","author":"Zhang","year":"2017","journal-title":"Arch Gynecol Obstet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0039-128X(00)00187-2","article-title":"Neuroendocrine effects of progesterone","volume":"65","author":"Chabbert-Buffeta","year":"2000","journal-title":"Steroids."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1210\/jc.2012-3676","article-title":"Antimullerian hormone levels are strongly associated with live-birth rates after assisted reproduction","volume":"98","author":"Brodin","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"B29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.fertnstert.2017.10.021","article-title":"Antimullerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the society for assisted reproductive technology clinic outcome reporting system database for 2012-2013","volume":"109","author":"Tal","year":"2018","journal-title":"Fertil Steril."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e81629","DOI":"10.1371\/journal.pone.0081629","article-title":"Ongoing pregnancy rates in women with low and extremely low AMH levels. a multivariate analysis of 769 cycles","volume":"8","author":"Kedem","year":"2013","journal-title":"PLoS ONE."},{"key":"B31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.rbmo.2018.03.015","article-title":"Very low anti-mullerian hormone concentrations are not an independent predictor of embryo quality and pregnancy rate","volume":"37","author":"Pacheco","year":"2018","journal-title":"Reprod Biomed Online."},{"key":"B32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.fertnstert.2014.09.041","article-title":"Antimullerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis","volume":"103","author":"Tal","year":"2015","journal-title":"Fertil Steril."},{"key":"B33","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.fertnstert.2013.03.031","article-title":"Does the time interval between antimullerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist?","volume":"100","author":"Polyzos","year":"2013","journal-title":"Fertil Steril."},{"key":"B34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam","year":"2004","journal-title":"Fertil Steril."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/1471-0528.14622","article-title":"The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial","volume":"124","author":"Dong","year":"2017","journal-title":"BJOG."},{"key":"B36","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF01133388","article-title":"A formula for scoring human embryo growth rates in in vitro fertilization: its value in predicting pregnancy and in comparison with visual estimates of embryo quality","volume":"3","author":"Cummins","year":"1986","journal-title":"J In Vitro Fert Embryo Transf."},{"key":"B37","first-page":"378","article-title":"In vitro culture of human blastocyst","volume-title":"Towards Reproductive Certainty: Infertility and Genetics Beyond 1999.","author":"Gardner","year":"1999"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod."},{"key":"B39","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics."},{"key":"B40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/humupd\/dmq034","article-title":"AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis","volume":"17","author":"Broer","year":"2011","journal-title":"Hum Reprod Update."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e108493","DOI":"10.1371\/journal.pone.0108493","article-title":"Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilisation who had discordant anti-Mullerian hormone and antral follicle count measurements: a retrospective study","volume":"9","author":"Li","year":"2014","journal-title":"PLoS ONE."},{"key":"B42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.fertnstert.2014.04.010","article-title":"Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles","volume":"102","author":"Reichman","year":"2014","journal-title":"Fertil Steril."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.fertnstert.2016.07.1068","article-title":"Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist","volume":"106","author":"Lu","year":"2016","journal-title":"Fertil Steril."},{"key":"B44","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.rbmo.2017.01.012","article-title":"A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF\/ICSI cycles","volume":"34","author":"Allegra","year":"2017","journal-title":"Reprod Biomed Online."},{"key":"B45","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.fertnstert.2016.10.033","article-title":"Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial","volume":"107","author":"Nyboe Andersen","year":"2017","journal-title":"Fertil Steril."},{"key":"B46","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.fertnstert.2013.12.032","article-title":"Female age-related fertility decline. committee opinion No. 589","volume":"101","year":"2014","journal-title":"Fertil Steril."},{"key":"B47","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00404-018-4786-5","article-title":"Clinical outcomes of frozen embryo versus fresh embryo transfer following in vitro fertilization: a meta-analysis of randomized controlled trials","volume":"298","author":"Zhang","year":"2018","journal-title":"Arch Gynecol Obstet."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00325\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:33:13Z","timestamp":1559046793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00325\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":47,"alternative-id":["10.3389\/fendo.2019.00325"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00325","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"article-number":"325"}}